Regenerative Medicine - from Protocol to Patient 3. Tissue Engineering, Biomaterials and Nanotechnology

Regenerative medicine is the main field of groundbreaking medical development and therapy using knowledge from developmental and stem cell biology as well as advanced molecular and cellular techniques. This collection of volumes, Regenerative Medicine: From Protocol to Patient, aims to explain the s...

Full description

Bibliographic Details
Other Authors: Steinhoff, Gustav (Editor)
Format: eBook
Language:English
Published: Cham Springer International Publishing 2016, 2016
Edition:3rd ed. 2016
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03907nmm a2200313 u 4500
001 EB001191734
003 EBX01000000000000000863870
005 00000000000000.0
007 cr|||||||||||||||||||||
008 160511 ||| eng
020 |a 9783319282749 
100 1 |a Steinhoff, Gustav  |e [editor] 
245 0 0 |a Regenerative Medicine - from Protocol to Patient  |h Elektronische Ressource  |b 3. Tissue Engineering, Biomaterials and Nanotechnology  |c edited by Gustav Steinhoff 
250 |a 3rd ed. 2016 
260 |a Cham  |b Springer International Publishing  |c 2016, 2016 
300 |a XIII, 244 p. 40 illus., 18 illus. in color  |b online resource 
505 0 |a 1 Novel technologies in design and fabrication of the 'living' bioprosthetic heart valves; natural scaffolds and synthetic polymers, Rosaria Santoro and Maurizio Pesce -- 2 Recent Progress in Strategies for Adenovirus Mediated Therapeutic Cell Targeting, Ottmar Herchenröder, Julia Reetz, and Brigitte M. Pützer -- 3 Regenerative chimerism bioengineered through stem cell reprogramming, Timothy J. Nelson , Almudena Martinez-Fernandez , Satsuki Yamada , and Andre Terzic -- 4 Biodegradable materials, Michael Schroeter, Britt Wildemann, and Andreas Lendlein -- 5 Biomaterials-Enabled Regenerative Medicine in Corneal Applications, Naresh Polisetti, Geeta K. Vemuganti, May Griffith -- 6 Functionalized Nanomaterials, Jie Zhou, Wenzhong Li, and Changyou Gao -- 7 Biointerface technology, Joachim Rychly -- 8 Controlled Release Technologies for RNAi Strategies in Regenerative Medicine, Jan Hoyer, Michael C. Hacker, Michaela Schulz‐Siegmund -- 9 Imaging technology, Cajetan Lang and Sebastian Lehner -- Index< 
653 |a Medicine / Research 
653 |a Stem cells 
653 |a Biology / Research 
653 |a Stem Cell Biology 
653 |a Biomedical Research 
653 |a Biomaterials 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
028 5 0 |a 10.1007/978-3-319-28274-9 
856 4 0 |u https://doi.org/10.1007/978-3-319-28274-9?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 610.72 
520 |a Regenerative medicine is the main field of groundbreaking medical development and therapy using knowledge from developmental and stem cell biology as well as advanced molecular and cellular techniques. This collection of volumes, Regenerative Medicine: From Protocol to Patient, aims to explain the scientific knowledge and emerging technology as well as the clinical application in different organ systems and diseases. International leading experts from all over the world describe the latest scientific and clinical knowledge of the field of regenerative medicine. The process of translating science of laboratory protocols into therapies is explained in sections on regulatory, ethical and industrial issues. The collection is organized into five volumes: (1) Biology of Tissue Regeneration, (2) Stem Cell Science and Technology, (3) Tissue Engineering, Biomaterials and Nanotechnology, (4) Regenerative Therapies I, and (5) Regenerative Therapies II. The textbook gives the student, the researcher, the health care professional, the physician and the patient a complete survey on the current scientific basis, therapeutical protocols, clinical translation and practiced therapies in regenerative medicine. Volume 3: Tissue engineering, Biomaterials and Nanotechnology focuses the development of technologies, which enable an efficient transfer of therapeutic genes and drugs exclusively to target cells and potential bioactive materials for clinical use. Principles of tissue engineering, vector technology, multifunctionalized nanoparticles, biodegradable materials, controlled release, and biointerface technology are described with regard to the development of new clinical cell technology. Imaging and targeting technologies as well as biological aspects of tissue and organ engineering are depicted